Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment.

Eiichi OgawaN FurusyoH NomuraK DohmenN HigashiK TakahashiA KawanoK AzumaT SatohM NakamutaT KoyanagiM KatoS ShimodaE KajiwaraJ Hayashinull null

Published in: Alimentary pharmacology & therapeutics (2017)

For cirrhotic patients after elimination of HCV, serum EOT-AFP level and previous HCC characteristics would be useful markers for predicting de novo HCC or recurrence.

Keyphrases

hepatitis c virus
end stage renal disease
human immunodeficiency virus
ejection fraction
newly diagnosed
chronic kidney disease
sars cov
prognostic factors
patient reported outcomes
hiv infected
replacement therapy